Natesto is the first and only FDA approved intranasal testosterone replacement therapy. Natesto is an androgen indicated for replacement therapy in adult males with a deficiency or absence of endogenous testosterone due to primary hypogonadism (congenital or acquired) or hypogonadotropic hypogonadism.
ProstaScint is an FDA-approved biologic indicated for the detection of prostate cancer. It is the only imaging agent that specifically targets prostate cancer cells and demonstrates high sensitivity, specificity, and accuracy. ProstaScint consists of a novel monoclonal antibody that, when conjugated to a linker-chelator and radiolabeled, binds distinctly to Prostate Specific Membrane Antigen (PSMA).
Primsol® (trimethoprim oral solution) is the only FDA-approved trimethoprim-only oral solution and is standard therapy for urinary tract infections. Trimethoprim has been widely prescribed to treat bacterial Urinary Tract Infections (UTI’s) due to Enterobacter Cloacae, E. Coli Bacteria, Klebsiella Bacteria, Proteus Bacteria, and Staphylococcus Aureus. Primsol is a sulfa-free, pleasant tasting liquid that is appropriate for patients that are sulfa allergic and individuals that have difficulty swallowing pills.